Thyroid Function Test Market Size

  • Report ID: 4797
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Thyroid Function Test Market Size

Thyroid Function Test Market size was valued at USD 3.18 billion in 2024 and is set to reach USD 9.62 billion by the end of 2037, expanding at around 8.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of thyroid function test is assessed at USD 3.41 billion..In addition to these, factors that are believed to fuel the thyroid function test market growth of thyroid function test include the new test launched in the market. For the detection and treatment of Grave’s disease, Mindray introduces the TRAb assay. Diagnoses for Graves' illness using TRAb have a sensitivity of 95.8% and a specificity of 96.7%. The most typical cause of hyperthyroidism is Graves' disease. Being the pathogenic antibody of Graves' disease, TRAb (thyrotropin receptor antibody) is regarded as one of the most significant serum indicators for diagnosis, clinical diagnosis, treatment monitoring, and prediction of Graves' disease.  On the other hand, the thyroid function test market growth is also attributed to rising cases of autoimmune diseases, such as Down syndrome, Hashimoto's thyroiditis, and others. People suffering from autoimmune diseases are at higher risk of getting affected by the thyroid.  


Thyroid Function Test Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4797
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of thyroid function test is assessed at USD 3.41 billion.

The thyroid function test market size was valued at USD 3.18 billion in 2024 and is set to reach USD 9.62 billion by the end of 2037, expanding at around 8.8% CAGR during the forecast period i.e., between 2025-2037. Increasing incidences of thyroid diseases and thyroid cancer, sedentary lifestyle of people, and growing intake of alcohol will boost the market growth.

North America industry is projected to be the largest with a share of about 38% by 2037, owing to rise in the number of people living with thyroid and increasing instances of thyroid cancer in the region.

The major players in the market include Abbott, Quest Diagnostics, Eli Lilly and Company, Autobio Diagnostics Co., Ltd., BioMérieux SA, Danaher Corporation, DiaSorin S, P.A., F. Hoffmann-La Roche Ltd., Qualigen Therapeutics Inc., Thermo Fisher Scientific Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample